Kidney nontumor
Other drug related toxicity
Tacrolimus (FK506) toxicity

Topic Completed: 3 September 2012

Minor changes: 17 February 2020

Copyright: 2002-2020,, Inc.

PubMed Search: Tacrolimus (FK506) toxicity [title] pathology

Related topics: Cyclosporin A toxicity

Nikhil Sangle, M.D.
Page views in 2019: 263
Page views in 2020 to date: 119
Cite this page: Sangle N. Tacrolimus (FK506) toxicity. website. Accessed May 28th, 2020.
Definition / general
  • Immunosuppressive drug used frequently in renal transplants, effect may be mediated by binding to FKBP12, a cytosolic protein
  • FKBP12/FK506 binds to and inactivates calcineurin (a serine / threonine phosphatase), which inhibits calcium and calmodulin dependent B and T cell responses by blocking NFAT-mediated transcription
Clinical features
  • Systemic levels of tacrolimus, if kept within a relatively narrow target window, may not be associated with nephrotoxicity (Transplant Proc 2009;41:3393)
  • The presence of rejection does not rule out Tacrolimus or Cyclosporine toxicity
  • Red cell exchange transfusion may be useful for severe toxicity (Pediatr Nephrol 2011;26:2245)
  • Although mechanism of action is similar to cyclosporine A, mechanisms causing nephrotoxicity may differ (J Proteomics 2011;75:677)
  • Reduce dosage
Microscopic (histologic) description
  • Toxicity (in 1%) is similar to cyclosporin A at level of renal vascular endothelium, leading to fibrin thrombi in glomerular capillaries and afferent arterioles (Am J Surg Pathol 1996;20:306, Am J Surg Pathol 1993;17:60)
  • May also cause arteriolar hyalinosis and splitting / reduplication of glomerular basement membrane
Microscopic (histologic) images

Images hosted on other servers:

Various images

Electron microscopy images

Images hosted on other servers:

Tubular vacuoles represent
dilatations of endoplasmic
reticulum and lysosomal elements
Back to top